Prestige Consumer Healthcare Operating Margin 2012-2025 | PBH
Current and historical operating margin for Prestige Consumer Healthcare (PBH) over the last 10 years. The current operating profit margin for Prestige Consumer Healthcare as of September 30, 2025 is 20.43%.
| Prestige Consumer Healthcare Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $1.11B | $0.33B | 29.88% |
| 2025-06-30 | $1.12B | $0.34B | 29.97% |
| 2025-03-31 | $1.14B | $0.34B | 29.53% |
| 2024-12-31 | $1.12B | $0.33B | 29.52% |
| 2024-09-30 | $1.11B | $0.33B | 29.25% |
| 2024-06-30 | $1.11B | $0.33B | 29.56% |
| 2024-03-31 | $1.13B | $0.34B | 30.40% |
| 2023-12-31 | $1.13B | $-0.02B | -1.85% |
| 2023-09-30 | $1.13B | $-0.02B | -1.86% |
| 2023-06-30 | $1.13B | $-0.03B | -2.21% |
| 2023-03-31 | $1.13B | $-0.02B | -2.04% |
| 2022-12-31 | $1.11B | $0.34B | 30.21% |
| 2022-09-30 | $1.11B | $0.33B | 29.90% |
| 2022-06-30 | $1.09B | $0.33B | 29.80% |
| 2022-03-31 | $1.09B | $0.33B | 30.39% |
| 2021-12-31 | $1.06B | $0.32B | 30.65% |
| 2021-09-30 | $1.02B | $0.31B | 30.72% |
| 2021-06-30 | $0.98B | $0.31B | 31.33% |
| 2021-03-31 | $0.94B | $0.30B | 31.50% |
| 2020-12-31 | $0.96B | $0.30B | 31.38% |
| 2020-09-30 | $0.96B | $0.30B | 31.60% |
| 2020-06-30 | $0.96B | $0.30B | 31.15% |
| 2020-03-31 | $0.96B | $0.29B | 30.11% |
| 2019-12-31 | $0.95B | $0.06B | 6.61% |
| 2019-09-30 | $0.95B | $0.07B | 6.83% |
| 2019-06-30 | $0.95B | $0.07B | 7.03% |
| 2019-03-31 | $0.98B | $0.07B | 6.97% |
| 2018-12-31 | $0.99B | $0.20B | 20.00% |
| 2018-09-30 | $1.02B | $0.20B | 20.00% |
| 2018-06-30 | $1.04B | $0.21B | 20.12% |
| 2018-03-31 | $1.04B | $0.22B | 20.73% |
| 2017-12-31 | $1.03B | $0.29B | 28.43% |
| 2017-09-30 | $0.97B | $0.28B | 28.47% |
| 2017-06-30 | $0.93B | $0.27B | 29.25% |
| 2017-03-31 | $0.88B | $0.21B | 23.22% |
| 2016-12-31 | $0.85B | $0.22B | 25.53% |
| 2016-09-30 | $0.83B | $0.21B | 25.33% |
| 2016-06-30 | $0.82B | $0.21B | 25.49% |
| 2016-03-31 | $0.81B | $0.26B | 32.38% |
| 2015-12-31 | $0.79B | $0.26B | 32.61% |
| 2015-09-30 | $0.79B | $0.25B | 31.93% |
| 2015-06-30 | $0.76B | $0.23B | 29.96% |
| 2015-03-31 | $0.72B | $0.21B | 29.09% |
| 2014-12-31 | $0.67B | $0.19B | 28.74% |
| 2014-09-30 | $0.62B | $0.18B | 28.46% |
| 2014-06-30 | $0.60B | $0.18B | 30.28% |
| 2014-03-31 | $0.60B | $0.19B | 31.44% |
| 2013-12-31 | $0.61B | $0.19B | 31.85% |
| 2013-09-30 | $0.62B | $0.20B | 32.21% |
| 2013-06-30 | $0.62B | $0.20B | 31.98% |
| 2013-03-31 | $0.62B | $0.19B | 30.97% |
| 2012-12-31 | $0.60B | $0.17B | 27.36% |
| 2012-09-30 | $0.55B | $0.14B | 25.87% |
| 2012-06-30 | $0.49B | $0.12B | 24.34% |
| 2012-03-31 | $0.44B | $0.10B | 23.36% |
| 2011-12-31 | $0.40B | $0.10B | 24.57% |
| 2011-09-30 | $0.39B | $0.09B | 22.68% |
| 2011-06-30 | $0.36B | $0.08B | 23.06% |
| 2011-03-31 | $0.34B | $0.08B | 22.92% |
| 2010-12-31 | $0.31B | $0.08B | 24.43% |
| 2010-09-30 | $0.29B | $0.09B | 29.31% |
| 2010-06-30 | $0.29B | $0.08B | 27.65% |
| 2010-03-31 | $0.29B | $0.08B | 26.96% |
| 2009-12-31 | $0.28B | $-0.17B | -60.42% |
| 2009-09-30 | $0.29B | $-0.17B | -60.63% |
| 2009-06-30 | $0.29B | $-0.17B | -59.59% |
| 2009-03-31 | $0.30B | $-0.17B | -58.31% |
| 2008-12-31 | $0.31B | $0.08B | 27.04% |
| 2008-09-30 | $0.31B | $0.09B | 27.83% |
| 2008-06-30 | $0.31B | $0.09B | 28.06% |
| 2008-03-31 | $0.32B | $0.09B | 28.25% |
| 2007-12-31 | $0.32B | $0.09B | 27.78% |
| 2007-09-30 | $0.32B | $0.09B | 28.40% |
| 2007-06-30 | $0.32B | $0.10B | 29.50% |
| 2007-03-31 | $0.32B | $0.10B | 29.78% |
| 2006-12-31 | $0.32B | $0.09B | 28.66% |
| 2006-09-30 | $0.32B | $0.09B | 28.66% |
| 2006-06-30 | $0.31B | $0.09B | 28.80% |
| 2006-03-31 | $0.30B | $0.08B | 28.38% |
| 2005-12-31 | $0.29B | $0.10B | 34.35% |
| 2005-09-30 | $0.29B | $0.10B | 35.54% |
| 2005-06-30 | $0.29B | $0.11B | 36.73% |
| 2005-03-31 | $0.30B | $0.10B | 33.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.114B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |